It is unusual for the CEO to be the presenter at these things — under the new Merck regime — so this might be worth a more careful listen. I’ll have a live blog window ready to go, should something material jump-off. We may hear whether Merck has bid — and, at what price — for Amylin Pharma.
In any event, here’s the presser:
. . . .Merck. . . announced today that Kenneth C. Frazier, Merck’s chairman and chief executive officer is scheduled to present at the Sanford C. Bernstein 28th Strategic Decisions Conference in New York City on May 31 at 8:00 a.m. EDT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation. . . .
We will tune in — and may live blog portions of it.